Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Transfusion01:15

Blood Transfusion

2.7K
Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
2.7K
Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

15.2K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
15.2K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

2.0K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
2.0K
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

606
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
606

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

From Thomas Mann to John Green, how authors and books shape our understanding of TB.

IJTLD open·2026
Same author

Novel method for trend change detection and hypothesis generation in hemovigilance: A transfusion-related immunomodulation and blood production changes study.

Transfusion·2026
Same author

Suppression of Take-All of Wheat by Seed Treatments with Fluorescent Pseudomonads.

Phytopathology·2025
Same author

Robotic-assisted anterior and posterior cervical spine surgeries.

Musculoskeletal surgery·2025
Same author

Redirecting venous flow from the superior mesenteric vein to the inferior mesenteric vein in resections for locally advanced pancreatic cancer.

Langenbeck's archives of surgery·2025
Same author

Fighting tuberculosis hand in hand: A call to engage communities affected by TB as essential partners in research.

PLOS global public health·2025

Related Experiment Video

Updated: Mar 6, 2026

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
11:59

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

7.9K

Group O RBCs: where is universal donor blood being used.

R L Barty1, M Pai2, Y Liu1

  • 1Department of Medicine and McMaster Centre for Transfusion Research, Faculty of Health Sciences, McMaster University, Hamilton, ON, Canada.

Vox Sanguinis
|March 22, 2017
PubMed
Summary
This summary is machine-generated.

Group O red blood cell (RBC) transfusions to non-O recipients are increasing, contributing to shortages. Targeted policies can improve the sustainable supply of group O RBCs.

Keywords:
blood groupquality managementred cell componentstransfusion medicine

More Related Videos

Transduction-Transplantation Mouse Model of Myeloproliferative Neoplasm
08:12

Transduction-Transplantation Mouse Model of Myeloproliferative Neoplasm

Published on: December 22, 2016

12.5K
Differentiation of Functional Osteoclasts from Human Peripheral Blood CD14+ Monocytes
11:52

Differentiation of Functional Osteoclasts from Human Peripheral Blood CD14+ Monocytes

Published on: January 27, 2023

4.6K

Related Experiment Videos

Last Updated: Mar 6, 2026

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
11:59

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

7.9K
Transduction-Transplantation Mouse Model of Myeloproliferative Neoplasm
08:12

Transduction-Transplantation Mouse Model of Myeloproliferative Neoplasm

Published on: December 22, 2016

12.5K
Differentiation of Functional Osteoclasts from Human Peripheral Blood CD14+ Monocytes
11:52

Differentiation of Functional Osteoclasts from Human Peripheral Blood CD14+ Monocytes

Published on: January 27, 2023

4.6K

Area of Science:

  • Transfusion Medicine
  • Hematology
  • Blood Banking

Background:

  • Recurrent shortages of group O red blood cells (RBCs) are a significant concern.
  • Insufficient inventory and transfusion of group O RBCs to ABO non-identical recipients contribute to these shortages.

Purpose of the Study:

  • To determine the utilization patterns of group O Rh-positive and Rh-negative RBCs based on recipient ABO group.
  • To assess the reasons for transfusing group O blood to ABO non-identical recipients over a 12-year period.

Main Methods:

  • A 12-year retrospective study (April 2002-March 2014) analyzed RBC transfusion data from three academic hospitals.
  • Data on product type, ABO/Rh group, disposition, and patient demographics were extracted from the Transfusion Registry for Utilization Surveillance and Tracking.
  • Descriptive statistics were employed to analyze the utilization trends.

Main Results:

  • A total of 314,968 RBC units were transfused, with 48.1% being group O.
  • While 91.1% of group O RBCs were transfused to group O recipients, 8.9% were given to ABO non-identical recipients.
  • The proportion of group O RBCs transfused to non-O recipients steadily increased from 7.8% to 11.1% between 2011 and 2013, driven by trauma, outdating, outpatient use, and shortages.

Conclusions:

  • The transfusion of group O RBCs to non-O individuals is an increasing practice.
  • Implementing targeted hospital and blood supplier policies can help optimize the use of group O RBCs.
  • Such strategies are crucial for ensuring a more sustainable supply of group O red blood cells.